Concepedia

Vivian Mumbiro

VM

4

Publications

58

Citations

4

H-Index

2022

Active since

Affiliations

University of Zimbabwe(Current)

Joint Clinical Research Centre

Radboud University Nijmegen

Radboud University Medical Center

University Teaching Hospital

Vivian Mumbiro is an author at University of Zimbabwe.

Publications per year

2022–2025

4

Publications

4

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

Anna Turkova, Hylke Waalewijn, Man K. Chan et al. · The Lancet HIV · 2022 · 23 citations · Full text

First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial

Hylke Waalewijn, Alexander J. Szubert, Roeland E. Wasmann et al. · Clinical Infectious Diseases · 2023 · 13 citations · Full text

Second-Line Antiretroviral Therapy for Children Living with HIV in Africa

Victor Musiime, Mutsa Bwakura‐Dangarembizi, Alexander J. Szubert et al. · New England Journal of Medicine · 2025 · 12 citations · Full text

Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial

Tom Jacobs, Vivian Mumbiro, Uneisse Cassia et al. · Clinical Infectious Diseases · 2023 · 10 citations · Full text

Rows per page

1–4 of 4